ALEC

Alector, Inc. Common Stock

2.53

USD

+0.07

+2.85%

Nov 10, 15:59 UTC -5

Closed

After-Market

2.46

-0.07

-2.77%

Alector, Inc. Common Stock (ALEC) Profile

Alector, Inc. Common Stock Profile

About

Alector Inc. is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Its product portfolio includes AL001, AL101, Al002 and AL003 which are in clinical stage. Alector Inc. is headquartered in South San Francisco, California.

Info & Links

CEO

Arnon Rosenthal

Headquarters

131 OYSTER POINT BLVD., SUITE 600
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

103

Alector, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

366.24M

Enterprise Value

290.77M

Enterprise Value/EBITDA(ttm)

7.10

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

18.36

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-850.13%

Profit Margin(ttm)

-851.41%

Return on Equity(ttm)

-531.03%

Return on Invested Capital(ttm)

121.42%

Return on Assets(ttm)

-44.00%

Income Statement

Revenue(ttm)

173.47M

Revenue Per Share(ttm)

1.17

Gross Profit(ttm)

173.47M

EBITDA(ttm)³

40.94M

Net Income Available to Common(ttm)

41.41M

Diluted EPS(ttm)

0.35

Share Statistics

Beta (5Y Monthly)

0.61

52-Week Change

97.66%

S&P 500 52-Week Change

16.37%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

148.88M

Dividend Yield

0.00%

Float⁴

102.39M

% Held by Insiders

8.30%

% Held by Institutions

85.83%

Balance Sheet

Total Cash(mrq)

138.70M

Total Cash Per Share(mrq)

0.93

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.10%

Quick Ratio(mrq)

5.26%

Book Value Per Share(mrq)

1.04

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.96

Free Cash Flow(ytd)

-108.03M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.